Dismantling the Fragility Index: A demonstration of statistical reasoning.

Go back to Resources

Dismantling the Fragility Index: A demonstration of statistical reasoning.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.

Go back to Resources

Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Intracerebral metastases in solid-tumor patients: natural history and results of treatment.

Go back to Resources

Intracerebral metastases in solid-tumor patients: natural history and results of treatment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

Go back to Resources

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical trials referral resource. Current phase III breast cancer clinical trials.

Go back to Resources

Clinical trials referral resource. Current phase III breast cancer clinical trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

Go back to Resources

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials of bortezomib.

Go back to Resources

Clinical trials referral resource. Current clinical trials of bortezomib.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

Go back to Resources

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.

Go back to Resources

Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Clinical trials of dolastatin-10.

Go back to Resources

Clinical trials referral resource. Clinical trials of dolastatin-10.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Subscribe to